The PMD-200^TM nociception monitor, developed by Medasense Ltd., helps you monitor your anaesthetized patients’ physiological pain response (nociception) to noxious stimuli and tailor analgesic medications to each patient’s specific sensitivity and needs. The integrated nociception level index (NOL^®)  provides superior indication of the presence and severity of pain response vs. individual parameters (such as changes in heart rate and blood pressure) to reduce complications and  improve patient outcomes.^1,2

[Available in Republic Of Ireland and Northern Ireland]

References:

• 1. Edry R et al., (2016),  Preliminary intraoperative validation of the NOL (Nociception Level) Index, a non-invasive nociception monitor. Anesthesiology July 2016, Vol.125, 193-203
• 2. Martini C.H. et al (2015),  Ability of the Nociception Level (NOL), a multiparameter composite of autonomic signals, to detect noxious stimuli during propofol-remifentanil anesthesia. Anesthesiology Sept. 2015; 123:524-534